51. Burkholderia Mallei tssM Encodes a Secreted Deubiquitinase that is Expressed Inside Infected RAW 264.7 Murine Macrophages
- Author
-
ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FORT DETRICK MD, Shanks, John, Burtnick, Mary N., Brett, PaulJ., Waag, David M., Spurgers, Kevin B., Ribot, Wilson J., Schell, Mark A., Panchal, Rekha G., Gherardini, Frank C., Wilkinson, Keith D., DeShazer, David, ARMY MEDICAL RESEARCH INST OF INFECTIOUS DISEASES FORT DETRICK MD, Shanks, John, Burtnick, Mary N., Brett, PaulJ., Waag, David M., Spurgers, Kevin B., Ribot, Wilson J., Schell, Mark A., Panchal, Rekha G., Gherardini, Frank C., Wilkinson, Keith D., and DeShazer, David
- Abstract
Burkholderia mallei, a category B biothreat agent, is a facultative intracellular pathogen that causes the zoonotic disease glanders. The B. mallei VirAG two-component regulatory system activates the transcription of ~60 genes, including a large virulence gene cluster encoding a type VI secretion system (T6SS). The B. mallei tssM gene encodes a putative ubiquitin-specific protease that is physically linked to, and transcriptionally co-regulated with, the T6SS gene cluster. Mass spectrometry and immunoblot analysis demonstrated that TssM was secreted in a virAG-dependent manner in vitro. Surprisingly, the T6SS was found to be dispensable for the secretion of TssM. The C-terminal half of TssM, which contains Cys and His box motifs conserved in eukaryotic deubiquitinases, was purified and biochemically characterized. Recombinant TssM (rTssM) hydrolyzed multiple ubiquitinated substrates and the cysteine at position 102 was critical for enzymatic activity. The tssM gene was expressed within 1 h after uptake of B. mallei into RAW 264.7 murine macrophages, suggesting that the TssM deubiquitinase is produced in this intracellular niche. While the physiological substrate(s) is currently unknown, the TssM deubiquitinase may provide B. mallei a selective advantage in the intracellular environment during infection., Sponsored in part by National Inst. of Allergy and Infectious Diseases grant no Y1-AI-5004-01, National Institute of Health grants no. GM030308 and GM066355, 1-R21-AI069081. Also project no. 22279 Pub. in Infection and Immunity, p1636-1648, v77 n4, Apr 2009.
- Published
- 2008